TITLE

Back to Drugs

PUB. DATE
February 2003
SOURCE
Shopping Center World;Feb2003, Vol. 32 Issue 2, p10
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
Reports on the increasing sales of the pharmaceutical industry in the U.S. as of February 2003. Growth of the generic drug segment; Percentage of the total revenue.
ACCESSION #
9112473

 

Related Articles

  • For drug makers, solid returns depend much on blockbusters.  // Drug Store News;1/20/2003, Vol. 25 Issue 1, p44 

    Reports on the increasing financial return of the brand-name drug manufacturers in Boston, Massachusetts. Escalation of sales profit; Advantages of eliminating unpromising drugs; Demand for blockbuster medications.

  • WHY DRUG COMPANIES ARE THE MOST PROFITABLE U.S. INDUSTRY.  // Health & Stress;2003, Issue 2, p1 

    Reports that pharmaceutical companies continued their supremacy as the most profitable industry the United States in 2001. Profits earned by Fortune 500 pharmaceutical companies; Shift to more expensive prescriptions; Factors that have allowed drug companies to gain substantial profits.

  • Drug industry confounds analysts' forecasts.  // Life Science Today;Jun2000, Vol. 1 Issue 3, p4 

    Focuses on the increased first quarter sales in drug industry in Europe. Percentage of the growth of sales; Impact of patent expiries on health reform; Advantage of patent protection of drugs.

  • CME spend reaches $1.4 billion; industry ups contribution. Liebman, Milton // Medical Marketing & Media;Sep2002, Vol. 37 Issue 9, p8 

    Reports on the increasing income of the Accreditation Council for Continuing Medical Education providers in the U.S. Contribution of the pharmaceutical industry; Alteration in financial reporting; Income of the publishing companies.

  • Old Copycats: Learn New Tricks. Desai, V. Subhash // Siliconindia;Mar2002, Vol. 6 Issue 3, p10 

    Focuses on the aspects of the pharmaceutical industry in India. Overview on the average profits and revenues of pharmaceutical companies; Complexities facing large and small pharmaceutical firms; Profitability and risks with drug discovery.

  • Negotiating and Structuring Strategic Alliances. Schulman, David; Zammit-Lucia, Joe; Easley, Chris // BioPharm International;Jun2002, Vol. 15 Issue 6, p72 

    Reports the difficulty in maintaining double-digit profit growth of pharmaceutical companies. Increase of value in determining biotechnology; Changes on the nature of biotechnology value; Generation of cash flow from technologies and products.

  • IMS Health Business Watch. Friedman, Katherine; Kulp, Katrina // Medical Marketing & Media;May2000, Vol. 35 Issue 5, p40 

    Reports on the increase in the sales for the United States pharmaceutical industry for the year 1999. Increase in sales due to increased use of medicine; Anti-ulcer drugs' domination of the market; Percentage of drug purchases from retail pharmacies.

  • Key pharmaceutical markets expect growth through 2005.  // Fairfield County Business Journal;04/16/2001, Vol. 40 Issue 16, p25 

    Focuses on the expected growth of pharmaceutical markets in Latin America. Average rate of sales expansion; Expected annual sales in Mexico; Factors affecting the pharmaceutical industry; Influence of currency changes on pharmaceutical sales; Projected healthcare market status.

  • Drug Industry Most Profitable.  // HealthFacts;May2002, Vol. 27 Issue 5, p3 

    Reports on the profitability of the drug industry in the U.S., according to the organization FamiliesUSA.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics